COVID-19 Medicine By DRDO: Everything To Know About DRDO's Covid-19 Medicine and Treatment.

COVID-19 Medicine By DRDO: Everything To Know About DRDO's Covid-19 Medicine, Development, Doses and Treatment with 2-deoxy-D-glucose(2-DG).

DRDO Developed COVID-19 Drug 2-DG In Collaboration With Dr Reddy's Laboratories

The Defence Research and Development Organization (DRDO) has been developed indigenously COVID-19 Medicine at Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of the DRDO, in collaboration with Dr Reddy's Laboratories (DRL), Hyderabad.


Newly developed Covid-19 Medicine 2-deoxy-D-glucose (2-DG) in India by Defence Research and Development Organization (DRDO) has got an emergency approval for as an adjunct therapy in moderate to severe COVID patients by the Drugs Controller General of India (DCGI).

Here's are below some important point's about DRDO'S Anti-Covid Drug-2-DG and how it helps in the Covid-19 treatment:

2-Deoxy-D-Glucose (2-DG), It is a modified glucose, this type Medicine has been used in therapeutic treatments as anti-cancer and anti-viral agent. Now DRDO has declared that it should be used as an additional treatment in moderate to severe COVID-19 patients and not for the mild symptoms.

DRDO Developed Covid-19 Medicine Dose:

2-DG comes in a powder form in a sachet and it is to be taken twice a day by dissolving with water, for at least a week.

How does DRDO Medicine 2-DG helps COVID-19 patients ?

It claims that this Covid Medicine leads to faster recovery in Covid-19 patients who are in moderate or severe symptoms. It also affirm that it reduce the dependence on oxygen supplement in patients and works against all variants of the Coronavirus.

Effectiveness of Covid-19 Medicine by DRDO, 2-Deoxy-D-Glucose (2-DG): 

After received permission for clinical trial on May 2020, Clinical research found that initially it's used for effective treatment of SARS-COV2, then DRDO and Dr Reddy's Laboratories (DRL) conducted phase-2 clinical trial on October 2020 on 110 patients. At phase-3 trials on November 2020 they were conducted trial on 220 patients admitted in hospital with moderate and severe symptoms of Covid-19, At the end clinical trials results have shown that the molecule helps in faster recovery of patients and became free from the supplemental oxygen by the end of Days 3. In an official statement DRDO explained.

Price Of 2-DG In the Market:

The final price of 2-DG has not been decided yet. It will be finalized by the DRDO partner Dr Reddy's Laboratories (DRL), which is manufacturing the Covid-19 Drug. How ever it is to be excepted that 2-DG will be a cheap Medicine.





Post a Comment

Previous Post Next Post